Trastuzumab, sold under the brandname Herceptin among others, is a
monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to
Find information about Herceptin® (trastuzumab), a targeted therapy for HER2
Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer. Who is ...
In clinical trials, about 2-3 percent of those treated with chemotherapy plus
trastuzumab had heart failure, compared to fewer than one percent of those
Mar 31, 2016 ... Consumer information about the breast cancer drug trastuzumab (Herceptin).
Side effects, drug interactions, dosing, and pregnancy and ...
Trastuzumab is used to treat new cases of breast cancer or disease that has
spread to other parts of the body. It may prevent the growth of some breast tumors
Trade Name: Herceptin <sup>®</sup>. Drug Type: Trastuzumab is a monoclonal antibody. (
For more detail, see "How Trastuzumab Works" section below).
Easy to read patient leaflet for trastuzumab. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Jul 13, 2016 ... Herceptin is the trade name of the drug trastuzumab. It was approved by the
United States Food and Drug Administration in 1998 for the ...
Aug 4, 2014 ... Read about the cancer treatment drug trastuzumab, also called Herceptin,
including what it is, how it works and possible side effects.
Find important safety information and patient resources for all of our currently